Effects of Inhaled Salbutamol Versus 0.9% Normal Saline on Duration of Hospital Stay in Transiennt Tachypnea of Newborn

Transient tachypnea of the newborn (TTN) is a common cause of respiratory distress in neonates, often requiring prolonged hospitalization and oxygen therapy. Enhancing lung fluid absorption using beta-agonists like salbutamol may reduce disease duration and hospital stay. Objective: To compare the effects of inhaled salbutamol versus 0.9% normal saline on the duration of hospital stay and oxygen therapy in neonates diagnosed with TTN. Methods: This randomized controlled trial was conducted at the department of Pediatric Medicine in the Ibn-e-Siena Hospital Multan from November 2023 to November 2024 and included 60 term or late preterm neonates with clinical and radiographic evidence of TTN. Participants were randomly assigned to receive either a single dose of inhaled salbutamol (0.15 ml/kg in 4 ml saline) or 4 ml of 0.9% saline via nebulization. Respiratory parameters were monitored, and the primary outcome was duration of hospital stay. Secondary outcomes included duration of oxygen therapy and improvements in respiratory rate and oxygen saturation. Data were analyzed using SPSS version 23.0, and an independent t-test was applied. A p-value ≤ 0.05 was considered statistically significant. Results: The mean duration of oxygen therapy was significantly lower in the salbutamol group (7.13 ± 2.16 hours) compared to the control group (11.67 ± 5.97 hours; p < 0.001). The mean duration of hospital stay was also shorter in the salbutamol group (3.33 ± 1.16 days) than in the control group (4.90 ± 1.49 days), although the difference was not statistically significant (p = 0.229). Baseline characteristics such as gestational age, birth weight, and maternal age were comparable between the groups. Conclusion: Inhaled salbutamol is effective in reducing the duration of oxygen therapy in neonates with TTN. Although not statistically significant, it may also contribute to shorter hospital stays. This intervention may be particularly beneficial in resource-constrained settings. Further larger-scale studies are warranted.

Authors

Institutions

Publication Details

Journal
Biological and Clinical Sciences Research Journal
Published
2025-06-30
DOI
https://doi.org/10.54112/bcsrj.v6i6.1801
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Inhaled Salbutamol Versus 0.9% Normal Saline on Duration of Hospital Stay in Transiennt Tachypnea of Newborn

Ansa Anam, Asif Javeed, Sidra Shahid, Saima Manzoor
Biological and Clinical Sciences Research Journal
Neonatal Respiratory Health Research
article

Effects of Inhaled Salbutamol Versus 0.9% Normal Saline on Duration of Hospital Stay in Transiennt Tachypnea of Newborn

Ansa Anam, Asif Javeed, Sidra Shahid, Saima Manzoor
article en

Abstract

Transient tachypnea of the newborn (TTN) is a common cause of respiratory distress in neonates, often requiring prolonged hospitalization and oxygen therapy. Enhancing lung fluid absorption using beta-agonists like salbutamol may reduce disease duration and hospital stay. Objective: To compare the effects of inhaled salbutamol versus 0.9% normal saline on the duration of hospital stay and oxygen therapy in neonates diagnosed with TTN. Methods: This randomized controlled trial was conducted at the department of Pediatric Medicine in the Ibn-e-Siena Hospital Multan from November 2023 to November 2024 and included 60 term or late preterm neonates with clinical and radiographic evidence of TTN. Participants were randomly assigned to receive either a single dose of inhaled salbutamol (0.15 ml/kg in 4 ml saline) or 4 ml of 0.9% saline via nebulization. Respiratory parameters were monitored, and the primary outcome was duration of hospital stay. Secondary outcomes included duration of oxygen therapy and improvements in respiratory rate and oxygen saturation. Data were analyzed using SPSS version 23.0, and an independent t-test was applied. A p-value ≤ 0.05 was considered statistically significant. Results: The mean duration of oxygen therapy was significantly lower in the salbutamol group (7.13 ± 2.16 hours) compared to the control group (11.67 ± 5.97 hours; p < 0.001). The mean duration of hospital stay was also shorter in the salbutamol group (3.33 ± 1.16 days) than in the control group (4.90 ± 1.49 days), although the difference was not statistically significant (p = 0.229). Baseline characteristics such as gestational age, birth weight, and maternal age were comparable between the groups. Conclusion: Inhaled salbutamol is effective in reducing the duration of oxygen therapy in neonates with TTN. Although not statistically significant, it may also contribute to shorter hospital stays. This intervention may be particularly beneficial in resource-constrained settings. Further larger-scale studies are warranted.

Biological and Clinical Sciences Research JournalVol. 6(6)
Ibn Sina Hospital (KW)
Openalex Percentile: Top 72%
Neonatal Respiratory Health Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.